Multiparametric Discovery Platform for Functional Antibody Variants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current molecular and strain discovery processes suffer from limited throughput, high costs, and lack of integration with multiparametric data inputs, leading to slow and non-optimal discovery of molecules or strains, particularly in antibody screening, which often focuses on binding affinity rather than downstream functions, excluding promising antibodies and requiring labor-intensive steps.

Innovation Solution

A modular, high-throughput platform combining large data inputs, empirical data, and machine learning to identify functional antibody variants by analyzing antibody-expressing cells and reporter cells in a simultaneous platform, enabling rapid identification and optimization of antibody variants with desired functional characteristics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional high throughput screening technologies are used to screen antibody variants, then binding affinity can be measured, but throughput is limited and the process is slow and costly

Engineering Contradiction:
Improvebinding affinity measurementVSAvoidthroughput of antibody variant screening
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The system partitions the antibody screening process into distinct functional assays (binding affinity, downstream functional activity) that can be performed in parallel on different cell populations, allowing simultaneous measurement of multiple parameters across large variant libraries without sequential bottlenecks

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces reporter cells as intermediaries that convert functional antibody-antigen interactions into measurable signals (e.g., fluorescence, luminescence), enabling high-throughput detection of downstream functional effects without requiring labor-intensive manual assessment of each antibody variant

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If screening focuses on binding affinity to select antibody candidates, then easy selection is achieved, but promising antibodies with weak binding but strong downstream function are excluded

Engineering Contradiction:
Improveease of antibody candidate selectionVSAvoidaccuracy of identifying functional antibody variants
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system evaluates antibody variants across multiple parameters including binding affinity, downstream functional activity, and cellular response metrics, transforming the selection criterion from a single parameter (binding affinity) to a multiparametric assessment that captures comprehensive functional performance

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The platform performs multiple functions simultaneously: measuring binding affinity, assessing downstream functional effects, and identifying rare functional variants in a single integrated system, making the screening process universally applicable to diverse antibody discovery needs without requiring separate specialized assays

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Quantity of substance

If antibody-producing cell lines with limited proliferation capacity are used, then initial antibody production is achieved, but throughput is limited and rare antibodies are only recovered when they happen to occur in small populations

Engineering Contradiction:
Improveantibody production titerVSAvoidthroughput of antibody variant discovery
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The invention transitions from screening limited numbers of antibody-producing cell lines to evaluating large populations of antibody variants expressed in suitable host cells, adding the dimension of population scale to the discovery process and enabling recovery of rare functional variants through statistical probability in large numbers

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Measurement precision

If traditional sequential screening processes are used to identify functional antibodies, then detailed functional characterization is achieved, but the process requires additional labor-intensive steps and cannot achieve very high throughput

Engineering Contradiction:
Improvefunctional characterization accuracyVSAvoidautomation level of screening process
Core Design Contradiction:
Measurement precisionVSExtent of automation

Solution Approach 1:

The system replaces manual, mechanical screening steps with automated flow cytometry-based detection and high-throughput imaging systems that automatically measure functional responses of large numbers of antibody variants, eliminating labor-intensive operations while maintaining detailed functional characterization capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20250290932A1Multiparametric discovery and optimization platform
Publication Date: 2025.09.18 TRIPLEBAR BIO INC
  • US20250290932A1 patent drawing
  • US20250290932A1 patent drawing
  • US20250290932A1 patent drawing

AI summary

Provided herein are systems and methods for screening desirable biological variants using a high-throughput integrated system. The integrated system may be configured to input a plurality of parameters from functional studies of biological variants under applied conditions, in conjunction with integrated libraries of biological variants, and filter the inputs to produce desirable biological variants based on an input performance requirement. The system may output optimized strains, molecules, or novel molecules expected to have a desirable functional characteristic. Accordingly, the methods and systems disclosed herein enable multi-parametric studies of biological diversity and conditional diversity in systems biology.